Literature DB >> 20185047

Rosiglitazone increases myocardial glucose metabolism in insulin-resistant cardiomyopathy.

David P Kao, Ronald M Witteles, Andrew Quon, Joseph C Wu, Sanjiv Sam Gambhir, Michael B Fowler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20185047      PMCID： PMC3835683          DOI： 10.1016/j.jacc.2009.08.085

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  6 in total

1.  Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.

Authors:  Jonathan Buchanan; Pradip K Mazumder; Ping Hu; Gopa Chakrabarti; Matthew W Roberts; Ui Jeong Yun; Robert C Cooksey; Sheldon E Litwin; E Dale Abel
Journal:  Endocrinology       Date:  2005-09-01       Impact factor: 4.736

2.  Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone.

Authors:  K Hällsten; K A Virtanen; F Lönnqvist; T Janatuinen; M Turiceanu; T Rönnemaa; J Viikari; T Lehtimäki; J Knuuti; P Nuutila
Journal:  Diabet Med       Date:  2004-12       Impact factor: 4.359

3.  Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.

Authors:  Gabriele Fragasso; Gianluca Perseghin; Francesco De Cobelli; Antonio Esposito; Altin Palloshi; Guido Lattuada; Paola Scifo; Giliola Calori; Alessandro Del Maschio; Alberto Margonato
Journal:  Eur Heart J       Date:  2006-03-01       Impact factor: 29.983

4.  Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  N Engl J Med       Date:  2007-05-21       Impact factor: 91.245

Review 5.  Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options.

Authors:  Ronald M Witteles; Michael B Fowler
Journal:  J Am Coll Cardiol       Date:  2008-01-15       Impact factor: 24.094

6.  Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET.

Authors:  T Ohtake; I Yokoyama; T Watanabe; T Momose; T Serezawa; J Nishikawa; Y Sasaki
Journal:  J Nucl Med       Date:  1995-03       Impact factor: 10.057
  6 in total
  3 in total

1.  Hydrogen sulfide alleviates cardiac contractile dysfunction in an Akt2-knockout murine model of insulin resistance: role of mitochondrial injury and apoptosis.

Authors:  Nan Hu; Maolong Dong; Jun Ren
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-03-12       Impact factor: 3.619

2.  Short-chain fatty acid propionate alleviates Akt2 knockout-induced myocardial contractile dysfunction.

Authors:  Linlin Li; Yinan Hua; Jun Ren
Journal:  Exp Diabetes Res       Date:  2011-09-22

3.  Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats.

Authors:  Jia Li; Yao-Ming Xue; Bo Zhu; Yong-Hua Pan; Yan Zhang; Chunxia Wang; Yuhao Li
Journal:  J Diabetes Res       Date:  2018-08-27       Impact factor: 4.011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.